β2M has been demonstrated to be a major prognosticatorof mortality in hemodialytic patients,independent of hemodialysis length, diabetes,malnutrition and chronic inflammation, suggestingthe clinical importance of lowering and periodicalmonitoring of serum β2M in these patients(36). Here, B2M is linked to diabetes mellitus.